[go: up one dir, main page]

CO5660292A2 - Pirimidinas 2-sustituidas - Google Patents

Pirimidinas 2-sustituidas

Info

Publication number
CO5660292A2
CO5660292A2 CO06006393A CO06006393A CO5660292A2 CO 5660292 A2 CO5660292 A2 CO 5660292A2 CO 06006393 A CO06006393 A CO 06006393A CO 06006393 A CO06006393 A CO 06006393A CO 5660292 A2 CO5660292 A2 CO 5660292A2
Authority
CO
Colombia
Prior art keywords
aand
cycloalkenyl
cycloalkyl
alkoxy
cyano
Prior art date
Application number
CO06006393A
Other languages
English (en)
Inventor
Anja Schwogler
Markus Gewehr
Bernd Muller
Thomas Grote
Wassilios Grammenos
I Blasco Jordi Tormo
Andreas Gypser
Carsten Blettner
Peter Schafer
Frank Schieweck
Oliver Wagner
Reinhard Stierl
Ulrich Schofl
Siegfried Strathmann
Joachim Rheinheimer
Maria Scherer
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of CO5660292A2 publication Critical patent/CO5660292A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

1.- Pirimidinas 2-sustituidas de la fórmula I en la que el índice y los sustituyentes tienen los significados siguientes:n es un número entero de 1 a 5;L es halógeno, ciano, cianato (OCN), alquilo C1-C8, alquenilo C2-C8, alquinilo C2-C8, -alcoxi C1-C6, alqueniloxi C2-C8, alquiniloxi C2-C8, cicloalquilo C3-C6, cicloalquenilo C4-C6, cicloalquiloxi C3-C6, cicloalqueniloxi C4-C6, nitro, C(=O)-A, -C(=O)-O-A, -C(=O)-N(AAND#39)A, C(AAND#39)(=N-OA), N(AAND#39)A, N(AAND#39)-C(=O)-A, N(AAND#39AND#39)-C(=O)-N(AAND#39)A, S(=O)m-A, S(=O)m-O-A o S(=O)m-N(AAND#39)A,m es 0, 1 ó 2;A, AAND#39, A" significan, independientemente, hidrógeno, alquilo C1-C6, alquenilo C2-C6, alquinilo C2-C6, cicloalquilo C3-C8, cicloalquenilo C3-C8, fenilo, pudiendo los radicales orgánicos estar parcial o completamente halogenados o sustituidos por nitro, cianato, ciano o alcoxi C1-C4; o pudiendo A y AAND#39 formar juntos con los átomos a los que están ligados un heterociclo saturado, parcialmente insaturado o aromático de cinco o seis miembros, que contiene uno a cuatro heteroátomos del grupo O, N o S,pudiendo los grupos alifáticos de las demás definiciones de L estar parcial o completamente halogenados o llevar uno a cuatro grupos Ru:Ru significa ciano, alcoxi C1-C6, cicloalquilo C3-C6, alqueniloxi C2-C8, alquiniloxi C2-C8, cicloalquenilo C4-C6, cicloalquiloxi C3-C6, cicloalqueniloxi C4-C6, -C(=O)-A, -C(=O)-O-A, -C(=O)-N(AAND#39)A, C(AAND#39)(=N-OA), N(AAND#39)A, N(AAND#39)-C(=O)-A, N(AAND#39AND#39)-C(=O)-N(AAND#39)A, S(=O)m-A, S(=O)m-O-A o S(=O)mN(AAND#39)A.
CO06006393A 2003-07-24 2006-01-24 Pirimidinas 2-sustituidas CO5660292A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10333857 2003-07-24
DE10357714 2003-12-09

Publications (1)

Publication Number Publication Date
CO5660292A2 true CO5660292A2 (es) 2006-07-31

Family

ID=34117367

Family Applications (1)

Application Number Title Priority Date Filing Date
CO06006393A CO5660292A2 (es) 2003-07-24 2006-01-24 Pirimidinas 2-sustituidas

Country Status (30)

Country Link
US (1) US7375108B2 (es)
EP (1) EP1651618B1 (es)
JP (1) JP2006528603A (es)
KR (1) KR20060052857A (es)
AP (1) AP2157A (es)
AR (1) AR045100A1 (es)
AT (1) ATE350370T1 (es)
AU (1) AU2004261373B8 (es)
BR (1) BRPI0412891A (es)
CA (1) CA2532718A1 (es)
CO (1) CO5660292A2 (es)
CR (1) CR8184A (es)
CY (1) CY1106391T1 (es)
DE (1) DE502004002570D1 (es)
DK (1) DK1651618T3 (es)
EA (1) EA010566B1 (es)
EC (1) ECSP066278A (es)
ES (1) ES2279395T3 (es)
HR (1) HRP20070057T3 (es)
IL (1) IL172848A0 (es)
MA (1) MA27949A1 (es)
MX (1) MXPA06000038A (es)
NZ (1) NZ545103A (es)
PE (1) PE20050882A1 (es)
PL (1) PL1651618T3 (es)
PT (1) PT1651618E (es)
SI (1) SI1651618T1 (es)
TW (1) TW200516075A (es)
UY (1) UY28436A1 (es)
WO (1) WO2005012261A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080132522A1 (en) * 2004-07-14 2008-06-05 Basf Aktiengesellschaft 2-Substituted Pyrimidines, Method for Their Production and Their Use for Controlling Pathogenic Fungi
CL2007002231A1 (es) * 2006-08-02 2008-04-11 Basf Ag Uso de compuestos derivados de 5-(het) arilpirimidina para combatir hongos daninos; compuestos derivados de 5-(het) arilpirimidina; agente fungicida; y agente farmaceutico.
NZ710405A (en) * 2010-11-16 2017-04-28 Acetylon Pharmaceuticals Inc Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
ES2929576T3 (es) 2013-10-08 2022-11-30 Acetylon Pharmaceuticals Inc Combinaciones de inhibidores de histona deacetilasa 6 y el inhibidor de Her2 lapatinib para el uso en el tratamiento del cáncer de mama
EP3055299B1 (en) 2013-10-10 2021-01-06 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
US10660890B2 (en) 2013-10-24 2020-05-26 National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government Nih Division Of Extramural Inventions And Technology Resources (Deitr) Treatment of polycystic diseases with an HDAC6 inhibitor
KR20160092018A (ko) 2013-12-03 2016-08-03 에이스틸론 파마수티컬스 인코포레이티드 히스톤 탈아세틸화효소 저해제 및 면역조절 약물의 조합
US9464073B2 (en) 2014-02-26 2016-10-11 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
AU2015288060A1 (en) 2014-07-07 2017-02-09 Acetylon Pharmaceuticals, Inc. Treatment of leukemia with histone deacetylase inhibitors
AU2015356779A1 (en) 2014-12-05 2017-07-13 University of Modena and Reggio Emilia Combinations of histone deacetylase inhibitors and bendamustine for use in the treatment of lymphoma
US10272084B2 (en) 2015-06-01 2019-04-30 Regenacy Pharmaceuticals, Llc Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
EP3445364A4 (en) 2016-04-19 2019-11-27 Acetylon Pharmaceuticals, Inc. HDAC INHIBITORS, ONLY OR IN COMBINATION WITH BTK INHIBITORS, FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
WO2018016596A1 (ja) * 2016-07-20 2018-01-25 国立大学法人東北大学 PPARαアゴニストを含有する、肺高血圧症の予防又は治療剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL362551A1 (en) 2000-06-13 2004-11-02 Basf Aktiengesellschaft Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
HUP0400210A3 (en) * 2001-03-15 2005-11-28 Basf Ag 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi
CA2467683C (en) 2001-11-19 2011-09-27 Basf Aktiengesellschaft 5-phenylpyrimidines, agents comprising the same, method for production and use thereof

Also Published As

Publication number Publication date
AR045100A1 (es) 2005-10-12
IL172848A0 (en) 2006-06-11
JP2006528603A (ja) 2006-12-21
ECSP066278A (es) 2006-07-28
EP1651618B1 (de) 2007-01-03
EP1651618A1 (de) 2006-05-03
CY1106391T1 (el) 2011-10-12
NZ545103A (en) 2008-06-30
TW200516075A (en) 2005-05-16
DE502004002570D1 (de) 2007-02-15
CA2532718A1 (en) 2005-02-10
ES2279395T3 (es) 2007-08-16
AU2004261373B8 (en) 2010-11-04
DK1651618T3 (da) 2007-05-14
EA200600212A1 (ru) 2006-08-25
US7375108B2 (en) 2008-05-20
AP2006003497A0 (en) 2006-02-28
BRPI0412891A (pt) 2006-10-03
MXPA06000038A (es) 2006-03-21
KR20060052857A (ko) 2006-05-19
SI1651618T1 (sl) 2007-06-30
PE20050882A1 (es) 2005-12-01
HRP20070057T3 (hr) 2007-07-31
UY28436A1 (es) 2005-02-28
AU2004261373A1 (en) 2005-02-10
AP2157A (en) 2010-09-13
MA27949A1 (fr) 2006-06-01
US20070105873A1 (en) 2007-05-10
PL1651618T3 (pl) 2007-05-31
CR8184A (es) 2006-10-06
AU2004261373B2 (en) 2010-08-19
WO2005012261A1 (de) 2005-02-10
ATE350370T1 (de) 2007-01-15
PT1651618E (pt) 2007-03-30
EA010566B1 (ru) 2008-10-30

Similar Documents

Publication Publication Date Title
AR117916A1 (es) Compuesto heterocíclico y su uso
CO5660292A2 (es) Pirimidinas 2-sustituidas
ES2601518T3 (es) Composiciones plaguicidas
CR10034A (es) Derivados de oxadiazol
CO6440540A2 (es) Nuevas pirazol-4-n-alcoxicarboxamidas como microbicidas
CO6241076A2 (es) Compuestos de benzamida y aplicaciones de los mismos
DOP2010000068A (es) Derivados de pirazol sustituidos
PE20141041A1 (es) Compuestos, metodos y formulaciones parasiticidas
CO6210770A2 (es) Compuestos 2-aril-5-heterociclil-ciclohexan-1, 3 diona y su uso como herbicidas
AR086474A1 (es) Compuestos de pirazol pesticidas
EA200901659A1 (ru) Соединения пиперазина с гербицидным действием
ECSP088805A (es) 2-(piridin-2-il)-pirimidinas como fungicidas
AR056536A1 (es) Compuestos de 2-amino-5- [4-(difluormetoxi)fenil]-5-fenilimidazolona como inhibidores de la beta secretasa (bace)
CY1107008T1 (el) Παραγωγο βενζιμιδαζολης και χρηση ως ανταγωνιστου υποδοχεα aii
CO6390026A2 (es) Derivados de isoxazol para uso como reguladores del crecimiento de plantas
WO2007125321A3 (en) Purine and deazapurine derivatives as pharmaceutical compounds
ATE507208T1 (de) Pyrimidin-verbindungen und diese enthaltende zusammensetzungen zur schädlingsbekämpfung
AR052866A1 (es) Fenil-metanonas monociclicas sustituidas
AR067691A1 (es) Derivados heterociclicos de sulfonimidoil, composiciones plaguicidas que los contienen y usos de los mismos para el control de plagas.
AR073136A1 (es) Compuestos de pirrol
AR072166A1 (es) Derivado de piperidina y su uso como inhibidor de renina superior
ECSP088149A (es) 3-acilaminobenzanilidas insecticidas
PE20120688A1 (es) Derivados de n1-acil-5-fluoropirimidinona
AR075975A1 (es) Compuestos heterociclicos y su uso como inhibidores de la glucogeno sintetasa quinasa 3
MY169179A (en) Novel piperidine compound or salt thereof

Legal Events

Date Code Title Description
FC Application refused